Psammomys obesus (sand rat), a new animal model of non-alcoholic fatty liver disease

被引:14
|
作者
Maislos, M [1 ]
Medvedovskv, V
Sztarkier, I
Yaari, A
Sikuler, E
机构
[1] Soroka UMC, Dept Med, Atherosclerosis & Metab Unit, Beer Sheva, Israel
[2] Ben Gurion Univ Negev, FOHS, IL-84105 Beer Sheva, Israel
[3] Soroka UMC, Dept Med B, Beer Sheva, Israel
[4] Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel
[5] Soroka UMC, Liver Res Lab, Beer Sheva, Israel
[6] Soroka UMC, Inst Pathol, Beer Sheva, Israel
关键词
NAFLD; animal model; Psammomys obesus; steatohepatitis;
D O I
10.1016/j.diabres.2005.09.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/aims: Non-alcoholic fatty liver disease (NAFLD) is an increasingly recognized condition that includes a spectrum of clinicopathologic conditions ranging from steatotosis to cirrhosis and liver failure. NAFLD is usually associated with features of the metabolic syndrome. No established therapies can be offered to patients with NAFLD. An appropriate animal model of NAFLD would be of help in understanding the mechanisms of the disease and in testing novel therapeutic modalities. Available animal models, such as ob/ob and db/db mice, are unsatisfactory since they show only partial resemblance to human NAFLD. Psammomys obesus (sand rat) is a well-established model of type-2 diabetes and obesity, which shares most metabolic parameters of the human metabolic syndrome. In the present study, we hypothesized that P. obesus will also show features of non-alcoholic fatty liver disease. Methods: Experimental and control animals were fed normal rat chow or either chow to which fiber (30% wheat straw) was added for 6-18 weeks. Body weight and capillary glucose were measured regularly. At sacrifice blood samples, liver and epididymal fat were obtained. Histology of the liver was blindly determined by a pathologist. Results: The experimental group showed increased body weight. liver and abdominal fat pad mass, raised plasma glucose, insulin and lipids. Also, alanine-aminotransferase (189 +/- 76 IU versus 86 +/- 26 IU; p < 0.0001) was significantly higher in the experimental than the control group. Microscopic examination of liver tissue demonstrated marked macrovesicular fat infiltration in the experimental group while it was histologicaly normal in the control animals (liver fat score 1.7 +/- 1.0 and 0.2 +/- 0.4; p < 0.0001, respectively). Conclusions: Fed a calorie-rich diet P. obesus develops a syndrome, which shares metabolic, laboratory and histopathologic characteristics compatible with human NAFLD. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 50 条
  • [31] Non-Alcoholic Fatty Liver Disease in HIV Infection
    Macias, Juan
    Pineda, Juan A.
    Real, Luis M.
    AIDS REVIEWS, 2017, 19 (01) : 35 - 46
  • [32] Ghrelin: a new treatment for non-alcoholic fatty liver disease?
    Delhanty, Patric J. D.
    van der Lely, Aart J.
    ENDOCRINE, 2013, 43 (02) : 247 - 248
  • [33] New Onset Diabetes and Non-Alcoholic Fatty Liver Disease after Liver Transplantation
    Andrade, Antonio R.
    Bittencourt, Paulo L.
    Codes, Liana
    Evangelista, Maria A.
    Castro, Alessandra O.
    Sorte, Ney Boa
    Almeida, Carolina G.
    Bastos, Jorge A.
    Cotrim, Helma P.
    ANNALS OF HEPATOLOGY, 2017, 16 (06) : 932 - 940
  • [34] Non-alcoholic fatty liver disease - What's new
    Roeb, Elke
    Steffen, Hans-Michael
    Bojunga, Joerg
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2016, 141 (07) : 494 - 496
  • [35] Liver transplantation and non-alcoholic fatty liver disease
    Petros Zezos
    Eberhard L Renner
    World Journal of Gastroenterology, 2014, (42) : 15532 - 15538
  • [36] The epidemiology of non-alcoholic fatty liver disease
    Bellentani, Stefano
    LIVER INTERNATIONAL, 2017, 37 : 81 - 84
  • [37] Non-alcoholic fatty liver disease and diabetes
    Reyes-Garcia, Rebeca
    Rozas-Moreno, Pedro
    Julio Llamoza-Torres, Camilo
    Mezquita-Raya, Pedro
    MEDICINA CLINICA, 2017, 148 (01): : 33 - 38
  • [38] Pediatric Non-Alcoholic Fatty Liver Disease
    Bush, Haley
    Golabi, Pegah
    Younossi, Zobair M.
    CHILDREN-BASEL, 2017, 4 (06):
  • [39] Non-alcoholic fatty liver disease and steatohepatitis
    Par Gabriella
    Horvath Gabor
    Par Alajos
    ORVOSI HETILAP, 2013, 154 (29) : 1124 - 1134
  • [40] Non-Alcoholic Fatty Liver Disease in Children
    Brecelj, Jernej
    Orel, Rok
    MEDICINA-LITHUANIA, 2021, 57 (07):